Hyderabad: DRL to get biosimilar platform

Hyderabad: City-based Dr Reddy’s Laboratories will install a FlexFactory, a single-use manufacturing platform, to expand biologics production capacity at its facility, said GE Healthcare in a statement.

FlexFactory will make Dr Reddy’s biopharmaceutical manufacturing set-up more flexible and efficient strengthening the company’s position in the global biosimilars market, it said.

FlexFactory is a centrally automation integrated, flexible biomanufacturing platform. It allows manufacturers to seamlessly establish biopharmaceutical manufacturing capacity within an existing building.